Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950170-25-090530
Filing Date
2025-06-26
Accepted
2025-06-26 18:24:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 29221
  Complete submission text file 0000950170-25-090530.txt   30751
Mailing Address 85 DAN ROAD CANTON MA 02021
Business Address 85 DAN ROAD CANTON MA 02021 781-575-0775
Organogenesis Holdings Inc. (Subject) CIK: 0001661181 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-89667 | Film No.: 251081693
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ORGANOGENESIS INC. 85 DAN ROAD CANTON MA 02021
Business Address
Ades Alan A. (Filed by) CIK: 0001757286 (see all company filings)

Type: SCHEDULE 13D/A